Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.990
-0.010 (-0.50%)
Aug 28, 2026, 3:59 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 196.58 million as of August 28, 2026. Its market cap has increased by 20.78% in one year.
Market Cap
196.58M
Enterprise Value
211.77M
Revenue
117.33M
Ranking
n/a
PE Ratio
18.10
Stock Price
1.99
ChartMarket Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 196.58M, a decrease of -7.11%. That is a compound annual growth rate of -0.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 196.58M | 18.94% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 354.54M |
| Auxly Cannabis Group | 332.42M |
| Cardiol Therapeutics | 315.42M |
| TerrAscend | 284.44M |
| Organigram Global | 236.50M |
| BioSyent | 178.11M |
| Medexus Pharmaceuticals | 159.02M |
| Grown Rogue International | 157.46M |